Literature DB >> 9315099

Allelotype of pediatric rhabdomyosarcoma.

M Visser1, C Sijmons, J Bras, R J Arceci, M Godfried, L J Valentijn, P A Voûte, F Baas.   

Abstract

An allelotype covering all autosomes was constructed for the embryonal form of childhood rhabdomyosarcoma (ERMS) in order to identify regions encompassing tumorsuppressor genes (TSG) involved in ERMS. Thusfar most studies were focussed on chromosome 11p15.5, which frequently shows loss of heterozygozity (LOH) in embryonal tumors like RMS and Wilms' tumor (WT). In this study we show that, besides LOH of chromosome 11p15.5 (72%), LOH of chromosome 16q was present in 54% of the tumors analysed. Delineation of these two regions shows that the smallest region of overlap (SRO) for chromosome 11 was between D11S988 and D11S922. This region, estimated to be 7 cM and 3-5 Mb, is also the location of the putative Wilms' tumor WT2 TSG. It contains several genes including IGF2 and potential tumorsuppressor genes like H19 and p57kip2, which might contribute to the carcinogenesis of RMS. Analysis of chromosome 16q LOH defined the SRO between D16S752 and D16S413. LOH of chromosome 16 is also found in other tumors, including WT. Our data suggest that genes involved in the development of RMS and WT may not only be similar for chromosome 11 but also for chromosome 16.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9315099     DOI: 10.1038/sj.onc.1201302

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  26 in total

1.  Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma.

Authors:  J Anderson; A Gordon; A McManus; J Shipley; K Pritchard-Jones
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

2.  CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV.

Authors:  Joseph G Pressey; Marilyn C Haas; Christine S Pressey; Virginia M Kelly; Jacqueline N Parker; G Yancey Gillespie; Gregory K Friedman
Journal:  Pediatr Blood Cancer       Date:  2012-03-09       Impact factor: 3.167

3.  Inhibition of MDM2 by RG7388 confers hypersensitivity to X-radiation in xenograft models of childhood sarcoma.

Authors:  Doris Phelps; Kathryn Bondra; Star Seum; Christopher Chronowski; Justin Leasure; Raushan T Kurmasheva; Steven Middleton; Dian Wang; Xiaokui Mo; Peter J Houghton
Journal:  Pediatr Blood Cancer       Date:  2015-04-01       Impact factor: 3.167

Review 4.  Genomic imprinting and cancer.

Authors:  J A Joyce; P N Schofield
Journal:  Mol Pathol       Date:  1998-08

5.  Paternal uniparental disomy with segmental loss of heterozygosity of chromosome 11 are hallmark characteristics of syndromic and sporadic embryonal rhabdomyosarcoma.

Authors:  Katherine M Robbins; Deborah L Stabley; Jennifer Holbrook; Rebecca Sahraoui; Alexa Sadreameli; Katrina Conard; Laura Baker; Karen W Gripp; Katia Sol-Church
Journal:  Am J Med Genet A       Date:  2016-09-02       Impact factor: 2.802

6.  Prohibitin-2 binding modulates insulin-like growth factor-binding protein-6 (IGFBP-6)-induced rhabdomyosarcoma cell migration.

Authors:  Ping Fu; Zhiyong Yang; Leon A Bach
Journal:  J Biol Chem       Date:  2013-09-03       Impact factor: 5.157

7.  Lost miRNA surveillance of Notch, IGFR pathway--road to sarcomagenesis.

Authors:  K Galoian; T Guettouche; B Issac; L Navarro; H T Temple
Journal:  Tumour Biol       Date:  2014-01

8.  Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group.

Authors:  Elai Davicioni; Michael J Anderson; Friedrich Graf Finckenstein; James C Lynch; Stephen J Qualman; Hiroyuki Shimada; Deborah E Schofield; Jonathan D Buckley; William H Meyer; Poul H B Sorensen; Timothy J Triche
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

9.  Betulinic acid induces apoptosis and inhibits hedgehog signalling in rhabdomyosarcoma.

Authors:  M Eichenmüller; B Hemmerlein; D von Schweinitz; R Kappler
Journal:  Br J Cancer       Date:  2010-06-01       Impact factor: 7.640

10.  Reprogramming of a melanoma genome by nuclear transplantation.

Authors:  Konrad Hochedlinger; Robert Blelloch; Cameron Brennan; Yasuhiro Yamada; Minjung Kim; Lynda Chin; Rudolf Jaenisch
Journal:  Genes Dev       Date:  2004-08-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.